drugset / Trial / NCT00004794

Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis

NCT00004794

Treatment

Summary

OBJECTIVES: I. Evaluate the safety and efficacy of intravenous cidofovir in patients with small peripheral cytomegalovirus retinitis. II. Obtain safety and efficacy data related to different dosages of cidofovir.

Timeline

Start
1995-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject CIDOFOVIR ANHYDROUS Small molecule Intravenous